Sie sind auf Seite 1von 16

e m B R A C E i n g

i n n o v a t i o n

the recurring pain


5,000,000 Americans Athletes Military Stroke victims General population
80-90% rate of recurrence

Treatment Option: Bracing

poor treatment option: the sully

thick rubber material sweaty!

side view of Sully brace

confusing strapping improper use

competitors instruction manual

lack of support redislocate

Amazon review

Riley Morgan Csernica


1990-present

tarian shoulder stabilizer


Clemsons Provisional Patent: US 61/691,929

comfortable self-applied supportive

future lines of tarian

Medical bracing and supports: $1.4 BILLION U.S. market

business feasibility
FDA requirements: No data required! All suppliers/manuf. in SC, NC, GA Easy access! Customer base: Highly eager!

High gross margins: 80% Funding to date: $26,000

financials

3-YEAR PROJECTIONS Braces sold (@ $250) Revenues Expenses

2013 20 $5,000 $42,782

2014 1535 $329,750 $277,761

2015 3422 $811,750 $488,760

Operating Margin

16%

40%

management
Co-founder, CEO: Riley Csernica, MBAR
MS Bioengineering (Clemson 13) NSF Grant Awardee

rcserni@g.clemson.edu 843-343-9494

Co-founder, COO: Chelsea Ex-Lubeskie, MS


Quality control at Baxter Healthcare Intern at Clemson Tech Transfer

B R A C E

Y O U R S E L F

Das könnte Ihnen auch gefallen